Hektas Ticaret T.A.S.
HEKTS.IS
Abajo encontrarás el precio en vivo de Hektas Ticaret T.A.S. (HEKTS.IS), un gráfico de 1 año, 8 indicadores (RSI, MACD, Bollinger, MA, EMA, Stochastic, ATR, Volumen) y el modo de comparación. Puedes añadir a tu cartera, marcar como favorito o configurar alertas de precio.
- Prev close
- $0.12
- Volume
- $20.23M
- Market cap
- $1.06B
- Currency
- USD (native TRY)
Financials
- 52w high
- ₺5.27
- 52w low
- ₺2.76
- 52w change
- 40.26%
- Day high
- ₺4.58
- Day low
- ₺4.28
- PEG
- 0.85
- Price / Book
- 246.11
- Beta (5Y)
- -0.31
- Enterprise value
- 48.42B
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- EPS (TTM)
- -₺0.42
- Payout ratio
- 0.00%
- Revenue (TTM)
- 5.62B
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Debt / Equity
- 75.09
- Current ratio
- 0.58
- Quick ratio
- 0.32
- Profit margin
- -63.18%
- Gross margin
- -2.98%
- Return on assets
- -6.11%
- Return on equity
- -23.47%
- Shares outstanding
- 8.43B
- Float
- 3.76B
Hektas Ticaret T.A.S. manufactures, imports, and markets agricultural products, fertilizers and veterinary medicines in Turkey. The company's crop protection products include fungicides, herbicides, insecticides, acaricides, fumigants and nemathists, harvesting aids and plant growth regulators, winter struggle medicines and summer oils, spreads-adhesives, biological products, and feromons. It also offers smart base, leaf, pure, and fertilizers; organominerals; drip irrigation; biological preparation; and other plant nutrition products. In addition, the company provides ruminant, poultry, and pet products, as well as environmental health and seeds products. Hektas Ticaret T.A.S. was incorporated in 1956 and is headquartered in Gebze, Turkey.
Analyst & Risk
- Beta (vs S&P 500)
- -0.31
- very stable
- 52-week change
- 40.26%
- Debt / Equity
- 75.09
- very high leverage
- Current ratio
- 0.58
- Quick ratio
- 0.32
- ROE
- -23.47%
- ROA
- -6.11%
- PEG ratio
- 0.85
- potentially undervalued
- EV / Revenue
- 8.62
- EV / EBITDA
- -26.35
- Revenue growth
- -18.70%
- EBITDA
- -1.84B
- Free cash flow
- -298.56M
- Total cash
- 1.98B
- Total debt
- 12B
- Insider holdings
- 55.37%
- Institutional
- 3.81%
Noticias recientes
- Altimmune Touts Pemvidutide Momentum Ahead of Phase 3 MASH TrialMarketBeat7m ago
- Uber reveals an unexpected problem behind the AI boomTheStreet9m ago
- Dow Jones Futures: Techs Fall After Dow Hits High, AI Shrugs Off Broadcom, Ciena; Jobs Report LoomsInvestor's Business Daily9m ago
- NMAA board approves 'one free transfer' rule; schools get final sayAlbuquerque Journal, N.M.11m ago
- New Mexico's AG files suit against sports betting firm KalshiAlbuquerque Journal, N.M.13m ago
- Why Ollie's (OLLI) Shares Are Sliding TodayStockStory14m ago
- Microsoft Held Up as AI Chips Sold Off. Is It the Safer Megacap Bet Now?Motley Fool15m ago
- Mitsubishi Electric to Launch Data-provision Service to Accelerate Adoption of Latest Power SemiconductorsBusiness Wire16m ago
Discusión en vivo
Iniciar sesión to join the discussion.
- Aún no hay comentarios. Sé el primero.